TY - JOUR
T1 - Genome-wide significant linkage in schizophrenia conditioning on occurrence of depressive episodes
AU - Hamshere, ML
AU - Williams, NM
AU - Norton, N
AU - Williams, H
AU - Cardno, AG
AU - Zammit, S
AU - Jones, Lisa
AU - Murphy, KC
AU - Sanders, RD
AU - McCarthy, G
AU - Gray, MY
AU - Jones, G
AU - Holmans, P
AU - O'Donovan, MC
AU - Owen, MJ
AU - Craddock, N
PY - 2005/11/18
Y1 - 2005/11/18
N2 - BACKGROUND: Schizophrenia shows substantial clinical heterogeneity. One common important clinical variable in presentation is the occurrence of episodes of major depression. METHODS: We undertook analyses in an attempt to detect loci that influence susceptibility to, or modify the clinical expression of, schizophrenia according to the occurrence of episodes of major depression. We used a logistic regression framework in which lifetime presence/absence of major depression was entered as a covariate in the linkage analysis of our UK schizophrenia affected sibling pair series (168 affected sibling pairs typed for a 10 cM map of microsatellite markers). RESULTS: Inclusion of presence/absence of depression as a covariate detected a genome wide significant linkage signal on chromosome 4q28.3 at 130.7 cM (LOD = 4.59; p = 0.038; increase in maximum LOD over univariate analysis (ILOD) = 3.62). Inclusion of the depression covariate also showed suggestive evidence of linkage on 20q11.21 (LOD = 4.10; expected to occur by chance 0.093 times per genome scan, ILOD = 2.83). CONCLUSIONS: Our findings identify loci that may harbour genes that play a role in susceptibility to, or modify the risk of, episodes of major depression in people with schizophrenia.
AB - BACKGROUND: Schizophrenia shows substantial clinical heterogeneity. One common important clinical variable in presentation is the occurrence of episodes of major depression. METHODS: We undertook analyses in an attempt to detect loci that influence susceptibility to, or modify the clinical expression of, schizophrenia according to the occurrence of episodes of major depression. We used a logistic regression framework in which lifetime presence/absence of major depression was entered as a covariate in the linkage analysis of our UK schizophrenia affected sibling pair series (168 affected sibling pairs typed for a 10 cM map of microsatellite markers). RESULTS: Inclusion of presence/absence of depression as a covariate detected a genome wide significant linkage signal on chromosome 4q28.3 at 130.7 cM (LOD = 4.59; p = 0.038; increase in maximum LOD over univariate analysis (ILOD) = 3.62). Inclusion of the depression covariate also showed suggestive evidence of linkage on 20q11.21 (LOD = 4.10; expected to occur by chance 0.093 times per genome scan, ILOD = 2.83). CONCLUSIONS: Our findings identify loci that may harbour genes that play a role in susceptibility to, or modify the risk of, episodes of major depression in people with schizophrenia.
UR - http://www.scopus.com/inward/record.url?scp=33745916481&partnerID=8YFLogxK
U2 - 10.1136/jmg.2005.035345
DO - 10.1136/jmg.2005.035345
M3 - Article
C2 - 16227524
SN - 1468-6244
VL - 43
SP - 563
EP - 567
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
ER -